Fig. 27From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseThe schematic 2D and 3D representations of compound C18, docked in the active site of AChE [47]Back to article page